Neil Wilkie
Tracked across 1 events · 7 articles · First seen Aug 05, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Mironid, a Glasgow-based biopharmaceutical company developing small molecule therapeutics for Autosomal Dominant Polycystic Kidney Disease (ADPKD), announced on August 5, 2026 that it raised $46 million in a Series B funding round. The round was…
Impact: As CEO, Neil Wilkie led the funding round and is central to Mironid's strategy, with his leadership directly influencing the company's trajectory.
Aug 05, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Neil Wilkie live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard